Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
09/01/2010 | CN101816730A Chinese medicinal composition for treating fire tooth and decayed tooth |
09/01/2010 | CN101816727A Chinese medicinal preparation for treating hemorrhoids |
09/01/2010 | CN101816720A Bonesetting and collaterals activating pills |
09/01/2010 | CN101816716A Medicament for treating psoriasis and preparation method thereof |
09/01/2010 | CN101816713A Garden balsam stem pain-relieving paste |
09/01/2010 | CN101816710A Chinese medicinal composition for treating gall-stone |
09/01/2010 | CN101816709A Dermatophytosis ointment |
09/01/2010 | CN101816705A Medicine for treating femoral head necrosis by three-needle injection and fumigation and preparation method thereof |
09/01/2010 | CN101816683A Chinese medicament for treating acute orchitis |
09/01/2010 | CN101816682A Quality detection method of paracetamol,caffeine, artificial cow-bezoar and amantadine hydrochloride tablets |
09/01/2010 | CN101816681A Quality detection method of infant paracetamol and amantadine hydrochloride particles |
09/01/2010 | CN101816473A Tinea-resistant deodorizing nourishing and health care fragrant shoe |
09/01/2010 | CN101816470A Magnetic medicament waist belt and preparation method thereof |
09/01/2010 | CN101284107B Medicine for curing cancers and preparation method thereof |
09/01/2010 | CN101229319B Cold cough oral liquid |
09/01/2010 | CN101209266B Compound sobering-up agent |
09/01/2010 | CN101181557B Chinese medicine composition for curing ankylosing spondylitis, rheumatism and rheumatoid as well as method of making the same |
09/01/2010 | CN101143162B Medicinal liquor for treating mastoproliferation and its preparing process |
09/01/2010 | CN101095939B Eyedrops and method for preparing the same |
09/01/2010 | CN101085062B Medicine for curing parkinson's disease and its preparing method |
09/01/2010 | CN101066418B Medicine containing colloidal bismuth for treating gastric uncer |
09/01/2010 | CN101062065B Sore carbuncle plaster |
08/31/2010 | US7786269 The antibodies or fragments specifically bind to an extracellular epitope of an Epstein Barr Virus latent membrane protein; anticarcinogenic agents; cancer vaccines |
08/31/2010 | US7786260 immunogenic; treating or preventing Helicobacter infection in a mammalian host; gastroduodenal disease |
08/31/2010 | US7785887 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes |
08/31/2010 | US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease |
08/31/2010 | US7785874 Compositions and methods for monosynaptic transport |
08/31/2010 | US7785870 Cell-specific expression/replication vector |
08/31/2010 | US7785824 Hydrolysed casein product comprising tripeptides IPP and/or VPP |
08/31/2010 | US7785810 Detection of adhesion of cancer cells to a matrix coated with adhesion molecules; inhibiting the metastatic activity by administration of a dipeptidyl peptidase IV inhibitor. |
08/31/2010 | US7785635 treating urinary tract infections, kidney stones in cats |
08/31/2010 | US7785634 Bone graft materials derived from mineralized gelatin |
08/31/2010 | US7785633 Administering fermented milk/cheese whey as active component; necrosis |
08/31/2010 | US7785599 Albumin fusion proteins |
08/31/2010 | US7785596 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders |
08/31/2010 | US7785585 Compositions comprising sclareol or derivatives thereof and uses thereof |
08/31/2010 | US7785581 Composition and method for reducing feces toxins and treating digestive disorders |
08/31/2010 | US7785569 Measuring stomach discharging; analyzing emisison in breath; calibration |
08/31/2010 | CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes |
08/26/2010 | WO2010096550A2 Lactobacillus supplement for alleviating type 1 diabetes |
08/26/2010 | WO2010096170A2 Inhibition of trna synthetases and therapeutic applications thereof |
08/26/2010 | WO2010095966A1 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector |
08/26/2010 | WO2010095690A1 Blood flow improving agent |
08/26/2010 | WO2010095494A1 Granules containing poorly soluble substance, tablet, and method for solubilizing poorly soluble substance |
08/26/2010 | WO2010095463A1 Immunopotentiating composition and process for producing same |
08/26/2010 | WO2010094789A1 Method for alleviating intestinal problems and novel bacterial strains therefor |
08/26/2010 | WO2010094693A1 Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix |
08/26/2010 | WO2010094128A1 Tissue-engineered cartilage from continuous flow culture |
08/26/2010 | WO2010094101A1 Vaccine composition against canine pyoderma, method of vaccinating against canine pyoderma, and use of staphylococcus intermedius toxoids |
08/26/2010 | WO2010056988A9 Methods of treating stroke using stem cell-like menstrual blood cells |
08/26/2010 | WO2010053517A3 Combination therapy to combat helminth resistance |
08/26/2010 | WO2010018461A3 Compositions comprising lactobacillus casei for improving resistance to common infectious diseases |
08/26/2010 | WO2009090190A9 Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene |
08/26/2010 | US20100215765 Antimicrobial Composition and a Method of Controlling Contamination and Infection Using Said Composition |
08/26/2010 | US20100215764 Pharmaceutical Composition For Treating Nephropathy and Healthy Food Comprising Herb Extracts |
08/26/2010 | US20100215763 Method of using the body's alternative cellular energy pigments (ACE-pigments) in the therapy of diseases |
08/26/2010 | US20100215762 Edible composition for treating cutaneous signs of ageing |
08/26/2010 | US20100215761 Composition for regulating lipid metabolism |
08/26/2010 | US20100215745 Compositions of spores of non pathogenic bacteria |
08/26/2010 | US20100215738 Prebiotic formulations and methods of use |
08/26/2010 | US20100215728 Skincare Methods |
08/26/2010 | US20100215722 Tissue Regeneration II |
08/26/2010 | US20100215720 Implantable optical system, method for developing it and applications |
08/26/2010 | US20100215718 Bone Graft Material Containment Structures |
08/26/2010 | US20100215717 Endothelial scaffolds |
08/26/2010 | US20100215715 Gel delivery system for tissue repair |
08/26/2010 | US20100215714 Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells |
08/26/2010 | US20100215696 Efficiently replicable heptitis c virus mutant, a heptitis c virus mutant comprising reporter gene, a method of preparing of hcv vaccine using the same and a method of screening anti hcv composition using the same |
08/26/2010 | US20100215693 Immunological herpes simplex virus antigens and methods for use thereof |
08/26/2010 | US20100215674 Enhancing the t-cells stimulatory capacity of human antigen presenting cells and their use in vaccination |
08/26/2010 | US20100215673 Method for treating inflammation and controlled-release material capable of providing same |
08/26/2010 | US20100215667 Methods and compositions of treatment for modulating the immune system of animals |
08/26/2010 | US20100215631 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof |
08/26/2010 | US20100215629 Treatment of tumors using t lymphocyte preparations |
08/26/2010 | US20100215628 Method for preparing cell populations with anti-tumor immune response activity |
08/26/2010 | US20100215627 Atopy cure baby dry milk with green tea and lactobacillus |
08/26/2010 | US20100215626 MRSA Decolonization Kit (MDK) |
08/26/2010 | US20100215624 Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell |
08/26/2010 | US20100215623 Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
08/26/2010 | US20100215622 Treatment of immunosuppression-related disorders |
08/26/2010 | US20100215621 Recombinant Adenoviruses Capable Of Regulating Angiogenesis |
08/26/2010 | US20100215620 The co-culture method of sphingomonas sp. bacterial strain and aspergillus sp. fungus strain, new anti-cancer and antibiotic glionitrins derived from this co-culture method, and pharmaceutical composition containing glionitrins or pharmaceutically acceptable salt thereof as an active ingredient |
08/26/2010 | US20100215619 Hla peptide therapy |
08/26/2010 | US20100215617 Enhanced medical implant |
08/26/2010 | US20100215580 Compositions and methods for enhancing transport through mucus |
08/26/2010 | CA2786891A1 Immunopotentiating composition and process for producing same |
08/26/2010 | CA2753480A1 Method for making lactic acid bacteria composition |
08/26/2010 | CA2752961A1 Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix |
08/26/2010 | CA2752679A1 Isolated monocyte populations and related therapeutic applications |
08/26/2010 | CA2750070A1 Method for alleviating intestinal problems and novel bacterial strains therefor |
08/25/2010 | EP2221363A1 System for the cell and development stage-specific selection of differentiating non-human embryonal stem cells, non-human embryonal germ cells, and adult stem cells |
08/25/2010 | EP2221360A1 Lactic acid bacterium having effect of lowering blood uric acid level |
08/25/2010 | EP2221359A1 Lactic acid bacteria having action of lowering blood uric acid level |
08/25/2010 | EP2220210A1 Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect |
08/25/2010 | EP1339738B1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
08/25/2010 | EP1228208B1 36p6d5: secreted tumor antigen |
08/25/2010 | EP1194580B2 In vitro reconstitution of segmented negative-strand rna viruses |
08/25/2010 | EP1181047B9 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product |
08/25/2010 | CN201558407U Medicine cap for treating apoplexy |
08/25/2010 | CN201558345U Health care sachet |